Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global biobanking market size reached US$ 53.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 77.6 Billion by 2027, exhibiting a growth rate (CAGR) of 6.18% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Biobanking refers to the process of analyzing and storing information of human biospecimens, which are collected from healthy volunteers or people with a particular condition. This information is used in research and academic studies to improve the understanding of health and different diseases. Presently, modern biobanks have large-scale analysis of specific disease biomarkers, which include biological or digital material with well-annotated clinical and biological data. They provide a basis for improving personalized medical approaches wherein effective biomarker identification is crucial for disease diagnosis and prognosis.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Biobanking Market Trends:

Biobanking nowadays is gaining widespread adoption in collecting high-quality and well-annotated human biospecimens, understanding the pathogenic mechanisms, and identifying therapeutic targets of coronavirus disease (COVID-19). Apart from this, due to the increasing prevalence of new infectious and chronic diseases, there is a rise in the demand for biobanking to develop diagnostics that can accurately and quickly identify pathogens. This can also be accredited to the growing aging population, in confluence with the escalating demand for regenerative medicine and personalized treatment across the globe. Moreover, developments in genomics, metagenomics, proteomics, disease biology, bioenergy, environmental remediation, and allied fields are contributing to the market growth. Besides this, health agencies of numerous countries are investing in virtual biobank network models that offer a faster and sustainable solution. These network models offer electronic databases that help investigators to locate biospecimens and data mining from multiple biobanks. Furthermore, leading market players are offering a diverse portfolio of biobanking products and services that enable sharing of insights and critical information to advancing science. These innovations are projected to strengthen the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on specimen type, biobank type, application and end user.

Breakup by Specimen Type:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others
     

Breakup by Biobank Type:

  • Population-based Biobanks
  • Disease-oriented Biobanks
     

Breakup by Application:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Therapeutics
  • Research
     

Breakup by End User:

  • Academic Institutions
  • Pharma and Biotech Companies
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc. and VWR Corporation (Avantor Inc.).

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Specimen Type, Biobank Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc. and VWR Corporation (Avantor Inc.).
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Biobanking Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Specimen Type
    6.1    Blood Products
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Solid Tissue
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Cell Lines
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Nucleic Acid
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Biobank Type
    7.1    Population-based Biobanks
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Disease-oriented Biobanks
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Application
    8.1    Therapeutics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Research
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by End User
    9.1    Academic Institutions
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Pharma and Biotech Companies
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Brooks Automation Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Bay Biosciences LLC
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Boca Biolistics
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Ctibiotech
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Cureline Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Firalis
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Greiner Bio-One International GmbH
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Hamilton Company
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Merck KGaA
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    ProteoGenex Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    Thermo Fisher Scientific Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    VWR Corporation (Avantor Inc.)
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio

List of Figures

Figure 1: Global: Biobanking Market: Major Drivers and Challenges
Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2021
Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2021
Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2021
Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2021
Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2021
Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Biobanking Industry: SWOT Analysis
Figure 81: Global: Biobanking Industry: Value Chain Analysis
Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biobanking Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2022-2027
Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2022-2027
Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Biobanking Market: Competitive Structure
Table 8: Global: Biobanking Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global biobanking market was valued at US$ 53.3 Billion in 2021.

We expect the global biobanking market to exhibit a CAGR of 6.18% during 2022-2027.

The high prevalence of chronic infectious diseases is catalyzing the need for biobanking to develop diagnostic procedures for early disease detection and effective treatment, which is currently driving the global biobanking market.

The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of biobanking procedures in collecting high-quality and well-annotated human biospecimens, understanding the pathogenic mechanisms, and identifying therapeutic targets of the coronavirus infection.

Based on the specimen type, the global biobanking market has been divided into blood products, solid tissue, cell lines, nucleic acid, and others. Among these, blood products currently exhibit a clear dominance in the market.

Based on the biobank type, the global biobanking market can be categorized into population-based biobanks and disease-oriented biobanks. Currently, disease-oriented biobanks hold the majority of the total market share.

Based on the application, the global biobanking market has been segmented into therapeutics and research, where research represents the largest market share.

Based on the end user, the global biobanking market can be bifurcated into academic institutions and pharma and biotech companies. Currently, academic institutions account for the majority of the global market share.

On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America, where Europe currently dominates the global market.

Some of the major players in the global biobanking market include Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc., and VWR Corporation (Avantor Inc.).

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links